|Bid||303.51 x 800|
|Ask||307.73 x 1100|
|Day's range||302.76 - 307.86|
|52-week range||180.07 - 317.81|
|Beta (5Y monthly)||1.31|
|PE ratio (TTM)||83.40|
|Earnings date||19 Jul 2023 - 24 Jul 2023|
|Forward dividend & yield||N/A (N/A)|
|1y target est||310.16|
Short-term macro challenges have not stopped these two companies from continuing to expand their businesses.
Last year may have scared investors away from the stock market. As the market recovers, some growth stocks with strong fundamentals may thrive. Two such revolutionary companies are virtual healthcare leader Teladoc Health (NYSE: TDOC), and robotic surgery leader Intuitive Surgical (NASDAQ: ISRG).
Intuitive Surgical, Inc. (ISRG) closed the most recent trading day at $306.90, moving +1.03% from the previous trading session.
While no one can say when these choppy waters might subside, it's worth pointing out that the S&P 500 has still delivered a total return of 200% over the past 10 years and 67% over the last five. Intuitive Surgical (NASDAQ: ISRG) operates in one of the most non-cyclical industries on Earth -- the healthcare space. The company specializes in a very lucrative sub-sector of this industry: the surgical robotics market, a space that Grand View Research estimates is on track to be worth $18 billion by the year 2030.
If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...
NextEra Energy (NYSE: NEE) is a company well worth knowing about and adding to your watch list. The company bills itself as the world's largest utility company, and it can claim that in large part due to its ownership of the Florida Power & Light Company, which is itself "America's largest electric utility that sells more power than any other utility ..." There's a lot to like, or love, about NextEra Energy.
Intuitive Surgical, Inc. (ISRG) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Intuitive Surgical (ISRG) outperforms the industry and the S&P 500 Index due to its strength in robotics.
Excluding his own Berkshire Hathaway, the answer would almost certainly be Apple (NASDAQ: AAPL). Buffett has invested more heavily in Apple than any other stock, by far. A little under half of your initial $2,500 would allow you to buy seven shares of Apple at the current price.
After a terrible 2022, the Nasdaq has come roaring back in 2023. In April the index traded flat as fears of a recession offset better-than-expected earnings reports from big tech stocks, but some top Nasdaq stocks jumped double digits. Keep reading to see the three top-performing stocks from the Nasdaq-100 in April to see if any of them are worth buying.
With 28 years (and counting) of development and expansion, Intuitive Surgical (NASDAQ: ISRG) has built quite a name for itself in the robotic-surgery market. Its state-of-the-art da Vinci Surgical Systems enable doctors to perform all sorts of minimally invasive surgeries (MIS). While the pandemic did have a short-term negative impact on elective procedures, Intuitive's revenue and net profits still managed to increase at a rapid pace over the past five years (see chart below).
Christopher Ruane reveals a duo of growth shares that are on his buy list... if he can purchase them at what he thinks is a good price. The post 2 growth stocks on my buy list appeared first on The Motley Fool UK.
Investors are optimistic about Abbott (ABT) on continued growth in the core Diagnostics arm.
Key Insights Institutions' substantial holdings in Intuitive Surgical implies that they have significant influence over...
The launch of OpenAI's ChatGPT and the rapid expansion of its user base (100 million active monthly users in January) triggered an intense race in the tech sector to rapidly explore and commercialize AI capabilities. Ark Investment Management's Big Ideas 2023 report claims that AI software can earn up to $14 trillion in revenues by 2030. Instead, opting for well-established companies with proven AI technologies can be an excellent way to tap into the $14 trillion AI revolution.
Shares of Intuitive Surgical (NASDAQ: ISRG) rose by 17.9% in April 2023, according to data from S&P Global Market Intelligence. The gains were driven by a surprisingly strong earnings report, followed by a flood of bullish analyst notes. The company behind the da Vinci line of robotic surgery systems beat Wall Street's expectations soundly in the first quarter of 2023.
Virtual healthcare company Teladoc Health (NYSE: TDOC) experienced some exceptional gains during the worst of the pandemic. When the pandemic subsided and hospitals reopened, investors expected telehealth services would no longer be in demand and dumped the company's stock, causing it to plummet. Teladoc, on the other hand, is demonstrating that it can not only survive but thrive in the post-pandemic market.
Amid an uncertain macroeconomic environment, Qiagen's (QGEN) first-quarter results reflect an impressive organic top line, led by strength in non-COVID-19 product groups.
Inspire Medical's (INSP) both geographic regions witness strong revenue growth in the first quarter.
Despite a year-over-year decrease, Omnicell's (OMCL) first-quarter revenues and earnings exceed the top end of the previously announced outlook amid an uncertain macroeconomic environment.
When we invest, we're generally looking for stocks that outperform the market average. And the truth is, you can make...
Make it two months in a row: The S&P 500 delivered a positive gain in both March and April after declining in February. Can you still buy the S&P 500's best-performing April stocks? Most of Chipotle's nice gain came after the company reported its first-quarter earnings results on April 25.
Johnson & Johnson (NYSE: JNJ) is a well-known consumer and healthcare company that has been in operation for more than a century. Meanwhile, Intuitive Surgical (NASDAQ: ISRG) has made a name for itself as the market leader in robotic surgery. Johnson & Johnson is wildly popular for its consumer brands, such as Band-Aids, Listerine, Neutrogena, and Tylenol.
Cathie Wood's ARK Autonomous Technology & Robotics ETF is known for investing in cutting-edge companies, whether their shares are up or down. Intuitive Surgical (NASDAQ: ISRG) is one of her current holdings -- and its stock is definitely up, surging about 20% in the past year thanks to renewed investor optimism about the robotic surgery market where it is the leader. With Intuitive Surgical, the star of the show is its razor-and-blade business model.
To catch full episodes of all The Motley Fool's free podcasts, check out our podcast center. Ron Gross: You could theoretically rest on your laurels, but if you do that for too long, then you run the risk of losing that monopolistic power. You probably won't lose it if you are a regulated monopoly or a legal monopoly, like a utility, but you could lose it if you're the dominant player in search, and you stopped innovating and ChatGPT isn't even on your radar for example.